WADA status TB-500 Thymosin 4 (TB-500) is associated with WADA category S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), under growth factors affecting regenerative capacity
It even has been studied in cancer patients
Xu X, Lemaire C, Grzych JM, Pierce RJ, Raccurt M, Mullier F, Zerimech F, Decavel JP, Peyrol S, Liu J, Fontaine J, Lafitte S, Capron A and Cesbron JY
This antioxidant action is essential for skin health, as it may help promote a clearer and more radiant complexion
For instance, AI can identify biomarkers predictive of therapy response, allowing clinicians to stratify patients and prescribe targeted treatments more likely to succeed
Growth Hormone-Related Peptides The CJC-1295 and Ipamorelin combination is among the most extensively studied growth hormone secretagogue combinations in peptide research